Mucosal Atrophy in Celiac Disease: Extent of Involvement, Correlation With Clinical Presentation, and Response to Treatment

Joseph A Murray, Alberto Rubio-tapia, Carol T. Van Dyke, Deanna L. Brogan, Mary A. Knipschield, Brian Lahr, Ashwin Rumalla, Alan R. Zinsmeister, Christopher J. Gostout

Research output: Contribution to journalArticle

129 Citations (Scopus)

Abstract

Background & Aims: Wireless capsule endoscopy provides an opportunity to study the macroscopic features in celiac disease by providing a magnified view of the intestinal mucosa. In this study, we evaluated the following: (1) the distribution of atrophy in untreated celiac disease, (2) the correlation between extent of changes and clinical manifestations, (3) the accuracy and interobserver agreement of wireless capsule endoscopy assessment, and (4) the effect of gluten withdrawal. Methods: Thirty-eight consecutive patients with untreated biopsy-proven celiac disease underwent wireless capsule endoscopy. Each subject was invited to undergo repeat testing after at least 6 months of gluten withdrawal. The video images of each patient were reviewed independently by 2 investigators. Results: Thirty-five (92%) subjects had visible atrophy detected by capsule endoscopy. Twenty-two (59%) subjects showed an extensive enteropathy, 12 (32%) had enteropathy limited to the duodenum, and only 1 had a jejunal enteropathy. No association was shown between the extent of the lesion and clinical manifestations. Capsule endoscopy had a better overall sensitivity for the detection of atrophy as compared with upper endoscopy (92% vs 55%, P = .0005), with a specificity of 100%. The overall interobserver agreement for the 2 reviewers was relatively high (% total agreement, 86.5%). After gluten withdrawal, the extent and the pattern of atrophy improved both qualitatively and quantitatively. Conclusions: Celiac disease affects a highly variable portion of the small intestine starting at the duodenum. The extent of visible enteropathy does not explain differences in clinical presentation. Most subjects with visually detected villous atrophy showed a clinically significant improvement after gluten withdrawal.

Original languageEnglish (US)
Pages (from-to)186-193
Number of pages8
JournalClinical Gastroenterology and Hepatology
Volume6
Issue number2
DOIs
StatePublished - Feb 2008

Fingerprint

Capsule Endoscopy
Celiac Disease
Glutens
Atrophy
Duodenum
Therapeutics
Intestinal Mucosa
Endoscopy
Small Intestine
Research Personnel
Biopsy

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Mucosal Atrophy in Celiac Disease : Extent of Involvement, Correlation With Clinical Presentation, and Response to Treatment. / Murray, Joseph A; Rubio-tapia, Alberto; Van Dyke, Carol T.; Brogan, Deanna L.; Knipschield, Mary A.; Lahr, Brian; Rumalla, Ashwin; Zinsmeister, Alan R.; Gostout, Christopher J.

In: Clinical Gastroenterology and Hepatology, Vol. 6, No. 2, 02.2008, p. 186-193.

Research output: Contribution to journalArticle

Murray, JA, Rubio-tapia, A, Van Dyke, CT, Brogan, DL, Knipschield, MA, Lahr, B, Rumalla, A, Zinsmeister, AR & Gostout, CJ 2008, 'Mucosal Atrophy in Celiac Disease: Extent of Involvement, Correlation With Clinical Presentation, and Response to Treatment', Clinical Gastroenterology and Hepatology, vol. 6, no. 2, pp. 186-193. https://doi.org/10.1016/j.cgh.2007.10.012
Murray, Joseph A ; Rubio-tapia, Alberto ; Van Dyke, Carol T. ; Brogan, Deanna L. ; Knipschield, Mary A. ; Lahr, Brian ; Rumalla, Ashwin ; Zinsmeister, Alan R. ; Gostout, Christopher J. / Mucosal Atrophy in Celiac Disease : Extent of Involvement, Correlation With Clinical Presentation, and Response to Treatment. In: Clinical Gastroenterology and Hepatology. 2008 ; Vol. 6, No. 2. pp. 186-193.
@article{13cfbe6ba3e049aabf091b09414a4cc8,
title = "Mucosal Atrophy in Celiac Disease: Extent of Involvement, Correlation With Clinical Presentation, and Response to Treatment",
abstract = "Background & Aims: Wireless capsule endoscopy provides an opportunity to study the macroscopic features in celiac disease by providing a magnified view of the intestinal mucosa. In this study, we evaluated the following: (1) the distribution of atrophy in untreated celiac disease, (2) the correlation between extent of changes and clinical manifestations, (3) the accuracy and interobserver agreement of wireless capsule endoscopy assessment, and (4) the effect of gluten withdrawal. Methods: Thirty-eight consecutive patients with untreated biopsy-proven celiac disease underwent wireless capsule endoscopy. Each subject was invited to undergo repeat testing after at least 6 months of gluten withdrawal. The video images of each patient were reviewed independently by 2 investigators. Results: Thirty-five (92{\%}) subjects had visible atrophy detected by capsule endoscopy. Twenty-two (59{\%}) subjects showed an extensive enteropathy, 12 (32{\%}) had enteropathy limited to the duodenum, and only 1 had a jejunal enteropathy. No association was shown between the extent of the lesion and clinical manifestations. Capsule endoscopy had a better overall sensitivity for the detection of atrophy as compared with upper endoscopy (92{\%} vs 55{\%}, P = .0005), with a specificity of 100{\%}. The overall interobserver agreement for the 2 reviewers was relatively high ({\%} total agreement, 86.5{\%}). After gluten withdrawal, the extent and the pattern of atrophy improved both qualitatively and quantitatively. Conclusions: Celiac disease affects a highly variable portion of the small intestine starting at the duodenum. The extent of visible enteropathy does not explain differences in clinical presentation. Most subjects with visually detected villous atrophy showed a clinically significant improvement after gluten withdrawal.",
author = "Murray, {Joseph A} and Alberto Rubio-tapia and {Van Dyke}, {Carol T.} and Brogan, {Deanna L.} and Knipschield, {Mary A.} and Brian Lahr and Ashwin Rumalla and Zinsmeister, {Alan R.} and Gostout, {Christopher J.}",
year = "2008",
month = "2",
doi = "10.1016/j.cgh.2007.10.012",
language = "English (US)",
volume = "6",
pages = "186--193",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Mucosal Atrophy in Celiac Disease

T2 - Extent of Involvement, Correlation With Clinical Presentation, and Response to Treatment

AU - Murray, Joseph A

AU - Rubio-tapia, Alberto

AU - Van Dyke, Carol T.

AU - Brogan, Deanna L.

AU - Knipschield, Mary A.

AU - Lahr, Brian

AU - Rumalla, Ashwin

AU - Zinsmeister, Alan R.

AU - Gostout, Christopher J.

PY - 2008/2

Y1 - 2008/2

N2 - Background & Aims: Wireless capsule endoscopy provides an opportunity to study the macroscopic features in celiac disease by providing a magnified view of the intestinal mucosa. In this study, we evaluated the following: (1) the distribution of atrophy in untreated celiac disease, (2) the correlation between extent of changes and clinical manifestations, (3) the accuracy and interobserver agreement of wireless capsule endoscopy assessment, and (4) the effect of gluten withdrawal. Methods: Thirty-eight consecutive patients with untreated biopsy-proven celiac disease underwent wireless capsule endoscopy. Each subject was invited to undergo repeat testing after at least 6 months of gluten withdrawal. The video images of each patient were reviewed independently by 2 investigators. Results: Thirty-five (92%) subjects had visible atrophy detected by capsule endoscopy. Twenty-two (59%) subjects showed an extensive enteropathy, 12 (32%) had enteropathy limited to the duodenum, and only 1 had a jejunal enteropathy. No association was shown between the extent of the lesion and clinical manifestations. Capsule endoscopy had a better overall sensitivity for the detection of atrophy as compared with upper endoscopy (92% vs 55%, P = .0005), with a specificity of 100%. The overall interobserver agreement for the 2 reviewers was relatively high (% total agreement, 86.5%). After gluten withdrawal, the extent and the pattern of atrophy improved both qualitatively and quantitatively. Conclusions: Celiac disease affects a highly variable portion of the small intestine starting at the duodenum. The extent of visible enteropathy does not explain differences in clinical presentation. Most subjects with visually detected villous atrophy showed a clinically significant improvement after gluten withdrawal.

AB - Background & Aims: Wireless capsule endoscopy provides an opportunity to study the macroscopic features in celiac disease by providing a magnified view of the intestinal mucosa. In this study, we evaluated the following: (1) the distribution of atrophy in untreated celiac disease, (2) the correlation between extent of changes and clinical manifestations, (3) the accuracy and interobserver agreement of wireless capsule endoscopy assessment, and (4) the effect of gluten withdrawal. Methods: Thirty-eight consecutive patients with untreated biopsy-proven celiac disease underwent wireless capsule endoscopy. Each subject was invited to undergo repeat testing after at least 6 months of gluten withdrawal. The video images of each patient were reviewed independently by 2 investigators. Results: Thirty-five (92%) subjects had visible atrophy detected by capsule endoscopy. Twenty-two (59%) subjects showed an extensive enteropathy, 12 (32%) had enteropathy limited to the duodenum, and only 1 had a jejunal enteropathy. No association was shown between the extent of the lesion and clinical manifestations. Capsule endoscopy had a better overall sensitivity for the detection of atrophy as compared with upper endoscopy (92% vs 55%, P = .0005), with a specificity of 100%. The overall interobserver agreement for the 2 reviewers was relatively high (% total agreement, 86.5%). After gluten withdrawal, the extent and the pattern of atrophy improved both qualitatively and quantitatively. Conclusions: Celiac disease affects a highly variable portion of the small intestine starting at the duodenum. The extent of visible enteropathy does not explain differences in clinical presentation. Most subjects with visually detected villous atrophy showed a clinically significant improvement after gluten withdrawal.

UR - http://www.scopus.com/inward/record.url?scp=38649129400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38649129400&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2007.10.012

DO - 10.1016/j.cgh.2007.10.012

M3 - Article

C2 - 18096440

AN - SCOPUS:38649129400

VL - 6

SP - 186

EP - 193

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 2

ER -